GSK-951A) manufacturers
- GSK951A
-
- $1980.00
-
2026-04-20
- CAS:1403602-33-4
- Purity:
- Supply Ability: 10g
|
| | GSK-951A) Basic information |
| Product Name: | GSK-951A) | | Synonyms: | GSK 951A
(GSK951A;GSK-951A);Pyrazolo[1,5-a]pyrimidine-3-carboxamide, N-(1,3-benzodioxol-5-ylmethyl)-5-(4-ethylphenyl)-4,5,6,7-tetrahydro-7-(trifluoromethyl)-, (5R,7S)- | | CAS: | 1403602-33-4 | | MF: | C24H23F3N4O3 | | MW: | 472.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1403602-33-4.mol |  |
| | GSK-951A) Chemical Properties |
| Boiling point | 660.7±55.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | pka | 14.08±0.60(Predicted) |
| | GSK-951A) Usage And Synthesis |
| Uses | GSK951A is a THPP analogue. GSK951A inhibits mycolic acid biosynthesis. GSK951A combines potency in culture with in vivo activity and lack of cytotoxicity[1]. | | References | [1] Cox JA, et al. THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria. Nat Microbiol. 2016;1:15006. DOI:10.1038/nmicrobiol.2015.6 |
| | GSK-951A) Preparation Products And Raw materials |
|